Security key
45258H106
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 24,382,712
- Total 13F value
- $127,497,003
- Share change
- +21,359,135
- Put/Call ratio
- 151%
- SEC-reported price per share
- $5.23
- Number of holders
- 67
- Value change
- +$111,804,992
- Number of buys
- 55
- Number of sells
- 11
- Shares outstanding
- 69,928,708
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
67
Top holders
10
IMMX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Previous quarter: Q3 2025
Immix Biopharma, Inc. SEC filings
Immix Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45258H106
Recent filing periods:
Ownership snapshot
Top reported holders of IMMX - Immix Biopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Saturn V Capital Manageme...
Disclosed value leader
Saturn V Capital Manageme...
Comparable rows
15/15
Latest evidence
26 Dec 2025
13D/G
13F
Lead comparable stake: 7%
13D/G row: Saturn V Capital Management LP
Showing 1-6 of 15 holder rows.
Quick read
Saturn V Capital Management LP leads the comparable SEC ownership view at 7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Saturn V Capital Management LP's linked filing trail.
Comparable ownership
Top 5
Saturn V Capital Management LP
7%
Bleichroeder LP
1.2%
VANGUARD GROUP INC
1%
GEODE CAPITAL MANAGEMENT, LLC
0.27%
MORGAN STANLEY
0.17%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Saturn V Capital Management LP |
13D/G
|
7%
|
$17,987,759
3,693,585 shares
|
$0 | 26 Dec 2025 |
| Bleichroeder LP |
13F
Company
|
1.2%
|
$1,776,500
850,000 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
1%
|
$1,526,039
730,162 shares
|
— | 30 Sep 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.27%
|
$391,870
187,476 shares
|
— | 30 Sep 2025 |
| MORGAN STANLEY |
13F
Company
|
0.17%
|
$252,200
120,670 shares
|
— | 30 Sep 2025 |
| STATE STREET CORP |
13F
Company
|
0.14%
|
$206,826
98,960 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
67
Shares
24,382,712
Rows available
67
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
31
Q4 2025 holders
67
Holder diff
36
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend